Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/2810
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sasson, Aya Mohr- | - |
dc.contributor.author | Zajicek, Michal | - |
dc.date.accessioned | 2022-08-11T16:04:49Z | - |
dc.date.available | 2022-08-11T16:04:49Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/2810 | - |
dc.description.abstract | Management of women presenting with vaginal bleeding with enhanced myometrial vascularity and suspected retained products of conception Aya Mohr-Sasson1,2,* , Michal Zajicek1,2 , Raoul Orvieto1,2 , Ziva Tamir1,2 , Eran Kassif1,2 , Roy Mashiach1,2 , Yael Inbar2,3 , Shlomo B. Cohen1,2 1Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, 5265601 Ramat-Gan, Israel 2Sackler School of Medicine, Tel-Aviv University, 6997801 Tel-Aviv, Israel 3Department of Diagnostic Imaging, Sheba Medical Center, Tel-Hashomer, 5265601 Ramat-Gan, Israel *Correspondence: Mohraya@gmail.com (Aya Mohr-Sasson) Academic Editor: Andrea Tinelli Submitted: 15 November 2021 Revised: 24 January 2022 Accepted: 24 January 2022 Published: 15 April 2022 Abstract Background: To describe the clinical course of women with acute vaginal bleeding and a finding of uterine enhanced myometrial vascularity (EVM) with suspected retained products of conception (RPOC) on vaginal ultrasound examination. Methods: A retrospective cohort study including women with EMV and suspected RPOC attending a single tertiary medical center between April 2018 to May 2020. Women with uterine EMV were identified from medical records of the ultrasound clinics. Demographic and clinical characteristics were retrieved from women’s medical files. Results: During the study period nine women met inclusion criteria. The preceding event in seven and in two of the women was first and second trimester abortions, respectively. Of those who underwent first trimester abortion, three were surgical, two were medical and two were spontaneous. Suspected RPOC and EMV were observed by ultrasound in all cases. Six of nine women (67%) underwent uncomplicated operative hysteroscopy with removal of RPOC, and three (33%), who had severe active bleeding due to vascular malformations (arterio-venous malformation-1, pseudo-aneurysm of uterine artery-1, other vascular malformation-1) were treated with uterine artery embolization prior to operative hysteroscopy. Conclusions: Work-up of women with episodes of uterine bleeding following curettage or abortion should include color/power Doppler ultrasonography for the detection of EMV. Although in most cases EMV is a benign sonographic finding that accompany RPOC and disappear after the removal of RPOC, in women who present with acute vaginal bleeding it might hint for the presence of vascular malformations that might cause life-threatening bleeding during additional surgical interventions. Keywords: uterine enhanced myometrial vascularity; uterine arteriovenous malformation; retained products of conception; color Doppler ultrasonography | en_US |
dc.subject | uterine enhanced myometrial vascularity | en_US |
dc.subject | uterine arteriovenous malformation | en_US |
dc.subject | retained products of conception | en_US |
dc.subject | color Doppler ultrasonography | en_US |
dc.title | Management of women presenting with vaginal bleeding with enhanced myometrial vascularity and suspected retained products of conception | en_US |
dc.type | Article | en_US |
Appears in Collections: | 2. Clinical and Experimental Obstetrics & Gynecology |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2709-0094-49-4-095.pdf | 1.79 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.